Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features.
Roumiguie M, Lesourd M, Zgheib J, Tollon C, Salin A, Alméras C, Doumerc N, Thoulouzan M, Soulié M, Gautier JR, Loison G, Assoun J, Vacher A, Aziza R, Malavaud B, Beauval JB, Ploussard G.
Roumiguie M, et al. Among authors: zgheib j.
Urol Oncol. 2020 May;38(5):386-392. doi: 10.1016/j.urolonc.2019.12.018. Epub 2020 Jan 13.
Urol Oncol. 2020.
PMID: 31948932